Brandon Capital

Financial Services · Venture Capital

Overview

Brandon Capital invests in the most promising biomedical opportunities that have the potential to improve the lives of patients.

Investor profile

Venture capital
Investments
26
5 of them startups
Hiring now
4
92 open roles
Rounds in 12 months
3
Exits
5
Focusshare of its companies
Health Care 80%Science & Engineering 20%Biotechnology 20%Education 10%
Where its companies are
United Kingdom 12%Australia 8%United States 4%Germany 4%
Stage of its companies
Series A 100%
Its companies, the freshest money firstAll 26 investments
Pathios TherapeuticsVenture round · 6 mo ago NRG TherapeuticsVenture round · 8 mo ago AstronautxSeries A $61M · 3 yr ago The University of Sydney60 roles EBR Systems, Inc16 roles AdvanCell11 roles Catalym5 roles Myricx Pharma Limited Azura Ophthalmics Pheontx Aravax Vaxxas
92 open roles at 4 of its companies
Hiring fastestroles opened in 30 days
The University of Sydney54 new roles in 30 days EBR Systems, Inc4 new roles in 30 days Catalym3 new roles in 30 days
Co-investorscompanies they hold together
Novartis Venture Fund 4 shared Omega Funds 2 shared Canaan Partners 2 shared
Similar investorstheir companies share markets and countries
Nextech Invest Taiho Ventures MPM BioImpact Omega Funds Novartis Venture Fund RA Capital Management Epidarex Capital Pontifax
Sources: its portfolio page, read Nov 3